Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radiation Increases Survival in Certain Lung Cancer Patients

By HospiMedica staff writers
Posted on 27 Jun 2006
Treating certain lung cancer patients with surgery followed by radiation therapy can improve their chances of long-term survival, according to a study of more than 7,000 patients. More...


The findings, which suggest the need to reconsider radiation therapy's role in treatment, were published in the June 10, 2006, issue of the Journal of Clinical Oncology.

"Post-operative radiation therapy has failed to demonstrate a survival benefit in the past, likely because previous studies used older equipment,” said Brian Lally, M.D., lead author of the study and a radiation oncologist at Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA). "Our study, which examines the results using modern equipment, shows survival benefit in select patients.”

The study assessed data from the Surveillance, Epidemiology, and End Results Database (SEER), a U.S. national program that gathers information on cancer cases from registries that represent 26% of the U.S. population.

The researchers discovered that in patients whose disease had metastasized to the regional lymph nodes between the lungs, overall survival at five years was 27% in patients receiving surgery plus radiation therapy, compared to 20% in patients who were treated with surgery alone.

In the past, the combination of surgery/radiation therapy was the standard of care for lung cancer. However, this practice changed significantly after an analysis of nine studies revealed that radiation therapy had an unfavorable effect on survival. The aim of Dr. Lally's study was to determine if the advances in radiation therapy technology would result in improved survival. Researchers evaluated results of 7,465 patients who had surgery for lung cancer. About half (47%) received radiation therapy after the surgery and 53% did not.

In all patients, the researchers discovered that radiation treatment did not impact survival. However, when patients were compared based on lymph node involvement, there were distinct differences. In patients where cancer had spread to high-risk regional lymph nodes, survival was improved with radiation therapy.

"For the patients who received surgery and radiation therapy, their survival was better than patients who received surgery alone,” said Dr. Lally. Dr. Lally also reported that researchers need to continue to investigate the improving technology in hopes that all patients can gain benefit. Today, radiation oncologists are utilizing PET-CT (positron emission tomography/computed tomography) and MRI (magnetic resonance imaging) to better visualize tumors and target them with radiation. Intensity-modulated radiation therapy (IMRT), another new technology, is able to regulate the radiation beam to deliver precise doses to specific areas within a tumor.



Related Links:
Wake Forest University Baptist Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.